Radiotherapy for benign disease; Assessing the risk of radiation-induced cancer following exposure to intermediate dose radiation

British Journal of Radiology

Volumn 88, Issue 1056, 2015, Pages

  McKeown, Stephanie R ^a   Hatfield, Paul ^b   Prestwich, Robin J D ^b   Shaffer, Richard E ^c   Taylor, Roger E ^d  

^a UNIVERSITY OF ULSTER   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^d SWANSEA UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACOUSTIC NEURINOMA; AGE RELATED MACULAR DEGENERATION; ANEURYSMAL BONE CYST; BENIGN DISEASE; BONE CANCER; BRAIN ARTERIOVENOUS MALFORMATION; BRAIN CANCER; CANCER PATIENT; CANCER RISK; CHOROIDAL HEMANGIOMA; CHRONIC ECZEMA; DISEASES; DUPUYTREN CONTRACTURE; ECZEMA; ENDOCRINE OPHTHALMOPATHY; FIBROMATOSIS; FOLLOW UP; GLOMUS TUMOR; GROUPS BY AGE; GYNECOMASTIA; HEMATOLOGIC MALIGNANCY; HETEROTOPIC OSSIFICATION; HUMAN; HYPERSALIVATION; IRRADIATION; JUVENILE NASOPHARYNGEAL ANGIOFIBROMA; KELOID; LEDDERHOSE DISEASE; LYMPHOID HYPERPLASIA; MALIGNANT LENTIGO; MENINGIOMA; ORBIT PSEUDOTUMOR; PEYRONIE DISEASE; PIGMENTED VILLONODULAR SYNOVITIS; PLANTAR FASCIITIS; PSORIASIS; PTERYGIUM; RADIATION DOSE; RADIATION EXPOSURE; RADIATION INDUCED NEOPLASM; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SALIVARY PLEOMORPHIC ADENOMA; SKIN CANCER; SOFT TISSUE CANCER; SUPPURATIVE HIDRADENITIS; THYROID CANCER; TRIGEMINUS NEURALGIA; VERTEBRA HEMANGIOMA; NEOPLASMS, RADIATION-INDUCED; RADIOTHERAPY DOSAGE; RISK;

HUMANS; NEOPLASMS, RADIATION-INDUCED; RADIOTHERAPY DOSAGE; RISK;

EID: 84948156343     PISSN: 00071285     EISSN: 1748880X     Source Type: Journal    
DOI: 10.1259/bjr.20150405     Document Type: Review

References (111)

1. Ali AM, Thariat J, Bensadoun RJ, Thyss A, Rostom Y, El-Haddad S, et al. The role of radiotherapy in the treatment of pterygium: a review of the literature including more than 6000 treated lesions. Cancer Radiotherapie 2011; 15: 140-7. doi: 10.1016/j. canrad.2010.03.020
2. Frau E, Rumen F, Noel G, Delacroix S, Habrand JL, Offret H. Low-dose proton beam therapy for circumscribed choroidal hemangiomas. Arch Ophthalmol 2004; 122: 471-5. doi: 10.1001/archopht.122.10.1471
3. Evans JR, Sivagnanavel V, Chong V. Radiotherapy for neovascular age-related macular degeneration. Cochrane Database Syst Rev 2010; (5): CD004004. doi: 10.1002/ 14651858.CD004004
4. Mendenhall WM, Lessner AM. Orbital pseudotumor. Am J Clin Oncol 2010; 33: 304-6. doi: 10.1097/ COC.0b013e3181a07567
5. Bartalena L, Baldeschi L, Dickinson AJ, Eckstein A, Kendall-Taylor P, Marcocci C, et al. Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy. Thyroid 2008; 18: 333-46. doi: 10.1089/ thy.2007.0315
6. Lo TC, Healy WL, Covall DJ, Dotter WE, Pfeifer BA, Torgerson WR, et al. Hetero-topic bone formation after hip surgery: prevention with single-dose postoperative hip irradiation. Radiology 1988; 168: 851-4. doi: 10.1148/radiology.168.3.3136510
7. Heyd R, Tselis N, Ackermann H, Röddiger SJ, Zamboglou N. Radiation therapy for painful heel spurs: results of a prospective randomized study. Strahlenther Onkol 2007; 183: 3-9. doi: 10.1007/s00066-007-1589-1
8. Niewald M, Seegenschmiedt MH, Micke O, Graeber S, Muecke R, Schaefer V, et al; German Cooperative Group on Radiotherapy for Benign Diseases (GCGBD) of the German Society for Radiation Oncology (DEGRO). Randomized, multicenter trial on the effect of radiation therapy on plantar fasciitis (painful heel spur) comparing a standard dose with a very low dose: mature results after 12 months' follow-up. Int J Radiat Oncol Biol Phys 2012; 84: e455-62. doi: 10.1016/j.ijrobp.2012.06.022
9. Heyd R, Seegenschmiedt MH. Anerysmal Bone Cyst (ABC). In: Seegenschmiedt MH, Makoski HB, Trott KR, Brady LW (eds). Radiotherapy for non-malignant disorders. New York, NY: Springer; 2008, 441-55.
10. Taylor R, Hatfield P, McKeown S, Prestwich R, Shaffer R. A review of the use of radiotherapy for the treatment of benign clinical conditions and benign tumours. London, UK: The Royal College of Radiologists; 2015. Available from: https://www.rcr.ac.uk/sites/default/files/publication/BFCO%2815%291-RTBenigndisease-web.pdf
11. Heyd R, Seegenschmiedt MH, Rades D, Winkler C, Eich HT, Bruns F, et al; German Cooperative Group on Radiotherapy for Benign Diseases. Radiotherapy for symptomatic vertebral hemangiomas: results of a multicenter study and literature review. Int J Radiat Oncol Biol Phys 2010; 77: 217-25. doi: 10.1016/j.ijrobp.2009.04.055
12. Ragoowansi R, Cornes PG, Glees JP, Powell BW, Moss AL. Ear-lobe keloids: treatment by a protocol of surgical excision and immediate postoperative adjuvant radiotherapy. Br J Plast Surg 2001; 54: 504-8. doi: 10.1054/bjps.2001.3656
13. Seegenschmiedt MH, Olschewski T, Guntrum F. Radiotherapy optimization in early-stage Dupuytren's contracture: first results of a randomized clinical study. Int J Radiat Oncol Biol Phys 2001; 49: 785-98. doi: 10.1016/S0360-3016(00)00745-8
14. Seegenschmiedt MH, Wielputz M, Hanslian E, Fehlauer F. Long-term outcome of radiotherapy for primary and recurrent Ledderhose disease. In: Eaton C, Seegenschmiedt MH, Bayat A, Gabbiani G, Werker PMN, Wach W (eds). Dupuytren's disease and related hyperproliferative disorders. Berlin/Heidelberg, Germany: Springer-Verlag; 2012. 409-27.
15. O'Sullivan B, Cummings B, Catton C, Bell R, Davis A, Fornasier V, et al. Outcome following radiation treatment for high-risk pigmented villonodular synovitis. Int J Radiat Oncol Biol Phys 1995; 32: 777-86.
16. Niewald M, Wenzlawowicz KV, Flecken-stein J, Wisser L, Derouet H, Rübe C. Results of radiotherapy for Peyronie's disease. Int J Radiat Oncol Biol Phys 2006; 64: 258-62. doi: 10.1016/j. ijrobp.2005.06.009
17. Sumila M, Notter M, Itin P, Bodis S, Gruber G. Long-term results of radiotherapy in patients with chronic palmo-plantar eczema or psoriasis. Strahlenther Onkol 2008; 184: 218-23. doi: 10.1007/s00066-008-1788-4
18. Tsang RW, Liu FF, Wells W, Payne DG. Lentigo maligna of the head and neck. Results of treatment by radiotherapy. Arch Dermatol 1994; 130: 1008-12. doi: 10.1001/ archderm.1994.01690080074010
19. de Vries AC, Bogaards NA, Hooft L, Velema M, Pasch M, Lebwohl M, et al. Interventions for nail psoriasis. Cochrane Database Syst Rev 2013; 1: CD007633. doi: 10.1002/ 14651858.CD007633.pub2
20. Combs SE, Engelhard C, Kopp C, Wiedenmann N, Schramm O, Prokic V, et al. Long-term outcome after highly advanced single-dose or fractionated radiotherapy in patients with vestibular schwannomas-pooled results from 3 large German centers. Radiother Oncol 2015; 114: 378-83. doi: 10.1016/j.radonc.2015.01.011
21. Assouline A, Levy A, Abdelnour-Mallet M, Gonzalez-Bermejo J, Lenglet T, Le Forestier N, et al. Radiation therapy for hypersaliva-tion: a prospective study in 50 amyotrophic lateral sclerosis patients. Int J Radiat Oncol Biol Phys 2014; 88: 589-95. doi: 10.1016/j. ijrobp.2013.11.230
22. Mendenhall WM, Mendenhall CM, Werning JW, Malyapa RS, Mendenhall NP. Salivary gland pleomorphic adenoma. Am J Clin Oncol 2008; 31: 95-9. doi: 10.1097/ COC.0b013e3181595ae0
23. Mendenhall WM, Amdur RJ, Vaysberg M, Mendenhall CM, Werning JW. Head and neck paragangliomas. Head Neck 2011; 33: 1530-4. doi: 10.1002/hed.21524
24. Chakraborty S, Ghoshal S, Patil VM, Oinam AS, Sharma SC. Conformal radiotherapy in the treatment of advanced juvenile nasopharyngeal angiofibroma with intracranial extension: an institutional experience. Int J Radiat Oncol Biol Phys 2011; 80: 1398-404. doi: 10.1016/j. ijrobp.2010.04.048
25. Frohlich D, Baaske D, Glatzel M. Radiotherapy of hidradenitis suppurativa-still valid today? [In German.] Strahlenther Onkol 2000; 176: 286-9.
26. Viani GA, Bernardes da Silva LG, Stefano EJ. Prevention of gynecomastia and breast pain caused by androgen deprivation therapy in prostate cancer: tamoxifen or radiotherapy? Int J Radiat Oncol Biol Phys 2012; 83: e519-24. doi: 10.1016/j. ijrobp.2012.01.036
27. Van Houtte P, Roelandts M, Kantor G. Radiotherapy indications for non-malignant diseases in 2014. [In French.] Cancer Radiother 2014; 18: 425-9. doi: 10.1016/j.canrad.2014.06.015
28. Seegenschmiedt MH, Katalinic A, Makoski H, Haase W, Gademann G, Hassenstein E. Radiation therapy of benign diseases: a pattern of care study in Germany. [In German.] Int J Radiat Oncol Biol Phys 2000; 47: 195-202. doi: 10.1016/S0360-3016(99)00537-4
29. Seegenschmiedt MH, Makoski H-B, Trott K-R, Brady LW (eds). Radiotherapy for non-malignant disorders. Contemporary concepts and clinical results. Berlin, Germany: Springer Science and Business Media; 2009.
30. Micke O, Seegenschmiedt MH. German Working Group of Radiotherapy of Benign Diseases Consensus guidelines for radiation therapy of benign diseases: a multicentre approach in Germany. Int J Radiat Oncol Biol Phys 2002; 52: 496-513. doi: 10.1016/ S0360-3016(01)01814-4
31. Marks LB, Ten Haken RK, Martel MK. Quantitative analyses of normal tissue effects in the clinic (QUANTEC): an introduction to the scientific issues. Int J Radiat Oncol Biol Phys 2010; 76 (Suppl. 3): S3-9. doi: 10.1016/j.ijrobp.2009.09.040
32. Hall EJ, Giaccia A. Radiobiology for the Radiologist. Philadelphia, PA: Lippincott Williams and Wilkins; 2011.
33. Hall EJ. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys 2006; 65: 1-7. doi: 10.1016/j.ijrobp.2006.01.027
34. Annual Symposium on Fundamental Cancer Research 1964; MD Anderson Hospital and Tumor Institute; University of Texas Health Science Center at Houston; Graduate School of Biomedical Sciences. Cellular radiation biology: a symposium considering radiation effects in the cell and possible implications for cancer therapy: a collection of papers presented at the eighteenth Annual Symposium on Fundamental Cancer Research 1964. Baltimore, MA: William and Wilkins 1965.
35. Brenner DJ. Exploring two two-edged swords. Radiat Res 2012; 178: 7-16. doi: 10.1667/RR3085.1
36. Shuryak I, Sachs RK, Brenner DJ. A new view of radiation-induced cancer. Radiat Prot Dosimetry 2011; 143: 358-64. doi: 10.1093/rpd/ncq389
37. Shuryak I, Brenner DJ, Ullrich RL. Radiation-induced carcinogenesis: mechanistically based differences between gamma-rays and neutrons, and interactions with DMBA. PLoS ONE 2011; 6: e28559. doi:10.1371/journal.pone.0028559
38. Gilbert ES, Stovall M, Gospodarowicz M, Van Leeuwen FE, Andersson M, Glimelius B, et al. Lung cancer after treatment for Hodgkin's disease: focus on radiation effects. Radiat Res 2003; 159: 161-73. doi: 10.1667/0033-7587(2003)159[0161: LCATFH]2.0.CO;2
39. Travis LB, Hill DA, Dores GM, Gospodarowicz M, van Leeuwen FE, Holowaty E, et al. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA 2003; 290: 465-75. doi: 10.1001/jama.290.4.465
40. van Leeuwen FE, Klokman WJ, Stovall M, Dahler EC, van't Veer MB, Noordijk EM, et al. Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease. J Natl Cancer Inst 2003; 95: 971-80. doi: 10.1093/jnci/ 95.13.971
41. Sachs RK, Brenner DJ. Solid tumor risks after high doses of ionizing radiation. Proc Natl Acad Sci U S A 2005; 102: 13040-5. doi: 10.1073/pnas.0506648102
42. Travis LB, Hill D, Dores GM, Gospodarowicz M, van Leeuwen FE, Holowaty E, et al. Cumulative absolute breast cancer risk for young women treated for Hodgkin lym-phoma. J Natl Cancer Inst 2005; 97: 1428-37. doi: 10.1093/jnci/dji290
43. Little MP, Stovall M, Smith SA, Kleinerman RA. A reanalysis of curvature in the dose response for cancer and modifications by age at exposure following radiation therapy for benign disease. Int J Radiat Oncol Biol Phys 2013; 85: 451-9. doi: 10.1016/j. ijrobp.2012.04.029
44. Preston DL, Ron E, Tokuoka S, Funamoto S, Nishi N, Soda M, et al. Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat Res 2007; 168: 1-64. doi: 10.1667/RR0763.1
45. Veiga LH, Lubin JH, Anderson H, de Vathaire F, Tucker M, Bhatti P, et al. A pooled analysis of thyroid cancer incidence following radiotherapy for childhood cancer. Radiat Res 2012; 178: 365-76. doi: 10.1667/RR2889.1
46. Jansen JT, Broerse JJ, Zoetelief J, Klein C, Seegenschmiedt HM. Estimation of the carcinogenic risk of radiotherapy of benign diseases from shoulder to heel. Radiother Oncol 2005; 76: 270-7. doi: 10.1016/j. radonc.2005.06.034
47. International Commission on Radiological Protection (ICRP). 1990 Recommendations of the ICRP. Ann ICRP 1991; 21: 1-201. doi: 10.1016/0146-6453(91)90009-6
48. Douple EB, Mabuchi K, Cullings HM, Preston DL, Kodama K, Shimizu Y, et al. Long-term radiation-related health effects in a unique human population: lessons learned from the atomic bomb survivors of Hiroshima and Nagasaki. Disaster Med Public Health Prep 2011; 5(Suppl. 1): S122-33. doi: 10.1001/dmp.2011.21
49. Preston DL, Cullings H, Suyama A, Funamoto S, Nishi N, Soda M, et al. Solid cancer incidence in atomic bomb survivors exposed in utero or as young children. J Natl Cancer Inst 2008; 100: 428-36. doi: 10.1093/jnci/djn045
50. Kumar S. Second malignant neoplasms following radiotherapy. Int J Environ Res Public Health 2012; 9: 4744-59. doi: 10.3390/ijerph9124744
51. Hsu WL, Preston DL, Soda M, Sugiyama H, Funamoto S, Kodama K, et al. The incidence of leukaemia, lym-phoma and multiple myeloma among atomic bomb survivors: 1950-2001. Radiat Res 2013; 179: 361-82. doi: 10.1667/RR2892.1
52. Ron E, Modan B, Preston D, Alfandary E, Stovall M, Boice JD Jr. Radiation-induced skin carcinomas of the head and neck. Radiat Res 1991; 125: 318-25. doi: 10.2307/ 3578117
53. Boaventura P, Oliveira R, Pereira D, Soares P, Teixeira-Gomes J. Head and neck basal cell carcinoma prevalence in individuals submitted to childhood X-ray epilation for tinea capitis treatment. Eur J Dermatol 2012; 22: 225-30. doi: 10.1684/ ejd.2012.1670
54. Lindelöf B, Eklund G. Incidence of malignant skin tumours in 14,140 patients after grenz-ray treatment for benign skin disorders. Arch Dermatol 1986; 122: 1391-95. doi: 10.1001/archderm.1986.01660240055015
55. Karagas MR, McDonald JA, Greenberg ER, Stukel TA, Weiss JE, Baron JA, et al. Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group. J Natl Cancer Inst 1996; 88: 1848-53. doi: 10.1093/ jnci/88.24.1848
56. Ron E, Modan B, Boice JD Jr, Alfandary E, Stovall M, Chetrit A, et al. Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med 1988; 319: 1033-9. doi: 10.1056/ NEJM198810203191601
57. Neglia JP, Robison LL, Stovall M, Liu Y, Packer RJ, Hammond S, et al. New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 2006; 98: 1528-37. doi: 10.1093/jnci/djj411
58. Chowdhary A, Spence AM, Sales L, Rostomily RC, Rockhill JK, Silbergeld DL. Radiation associated tumors following therapeutic cranial radiation. Surg Neurol Int 2012; 3: 48. doi: 10.4103/2152-7806.96068
59. Godlewski B, Drummond KJ, Kaye AH. Radiation induced meningiomas after high dose cranial irradiation. J Clin Neurosci 2012; 19: 1627-35. doi: 10.1016/j. jocn.2012.05.011
60. Rowe J, Grainger A, Walton L, Silcocks P, Radatz M, Kemeny A. Risk of malignancy after gamma knife stereotactic radiosurgery. Neurosurgery 2007; 60: 60-5. doi: 10.1227/ 01.NEU.0000255492.34063.32
61. Paulino AC, Ahmed IM, Mai WY, Teh BS. The influence of pretreatment characteristics and radiotherapy parameters on time interval to development of radiation-associated meningioma. Int J Radiat Oncol Biol Phys 2009; 75: 1408-14. doi: 10.1016/j. ijrobp.2009.01.052
62. Armstrong GT, Liu W, Leisenring W, Yasui Y, Hammond S, Bhatia S, et al. Occurrence of multiple subsequent neoplasms in long-term survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol 2011; 29: 3056-64. doi: 10.1200/JCO.2011.34.6585
63. Hasegawa T, Kida Y, Kato T, Iizuka H, Kuramitsu S, Yamamoto T. Long-term safety and efficacy of stereotactic radio-surgery for vestibular schwannomas: evaluation of 440 patients more than 10 years after treatment with Gamma Knife surgery. J Neurosurg 2013; 118: 557-65. doi: 10.3171/2012.10.JNS12523
64. Sadetzki S, Chetrit A, Lubina A, Stovall M, Novikov I. Risk of thyroid cancer after childhood exposure to ionizing radiation for tinea capitis. J Clin Endocrinol Metab 2006; 91: 4798-804. doi: 10.1210/ jc.2006-0743
65. Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern LM, et al. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 1995; 141: 259-77. doi: 10.2307/ 3579003
66. Shore RE, Hildreth N, Woodard E, Dvoretsky P, Hempelmann L, Pasternack B. Breast cancer among women given X-ray therapy for acute postpartum mastitits. J Natl Cancer Inst 1986; 77: 689-96.
67. Mattsson A, Rudén BI, Palmgren J, Rutqvist LE. Dose- and time- response for breast cancer risk after radiation therapy for benign breast disease. Br J Cancer 1995; 72: 1054-61. doi: 10.1038/bjc.1995.461
68. Lundell M, Mattsson A, Hakulinen T, Holm LE. Breast cancer after radiotherapy for skin hemangioma in infancy. Radiat Res 1996; 145: 225-30. doi: 10.2307/3579178
69. Travis LB, Gospodarowicz M, Curtis RE, Clarke EA, Andersson M, Glimelius B, et al. Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. J Natl Cancer Inst 2002; 94: 182-92. doi: 10.1093/jnci/94.3.182
70. Moskowitz CS, Chou JF, Wolden SL, Bernstein JL, Malhotra J, Novetsky Friedman D, et al. Breast cancer after chest radiation therapy for childhood cancer. J Clin Oncol 2014; 32: 2217-23.doi: 10.1200/JCO.2013.54.4601
71. Davis FG, Boice JD Jr, Hrubec Z, Monson RR. Cancer mortality in a radiation-exposed cohort of Massachusetts tuberculosis patients. Cancer Res 1989; 49: 6130-6.
72. Brenner DJ, Curtis RE, Hall EJ, Ron E. Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery. Cancer 2000; 88: 398-406. doi: 10.1002/(SICI)1097-0142(20000115)88: 2,398::AID-CNCR22.3.0.CO;2-V
73. Kim JH, Chu FC, Woodard HQ, Melamed MR, Huvos A, Cantin J. Radiation-induced soft-tissue and bone sarcoma. Radiology 1978; 129: 501-8. doi: 10.1148/129.2.501
74. Henderson TO, Rajaraman P, Stovall M, Constine LS, Olive A, Smith SA, et al. Risk factors associated with secondary sarcomas in childhood cancer survivors: a report from the childhood cancer survivor study. Int J Radiat Oncol Biol Phys 2012; 84: 224-30. doi: 10.1016/j.ijrobp.2011.11.022
75. Schwartz B, Benadjaoud MA, Cléro E, Haddy N, El-Fayech C, Guibout C, et al. Risk of second bone sarcoma following childhood cancer: role of radiation therapy treatment. Radiat Environ Biophys 2014; 53: 381-90. doi: 10.1007/s00411-013-0510-9
76. Sakata R, Kleinerman RA, Mabuchi K, Stovall M, Smith SA, Weathers R, et al. Cancer mortality following radiotherapy for benign gynecologic disorders. Radiat Res 2012; 178: 266-79. doi: 10.1667/RR2845.1
77. Brown WM, Doll R. Mortality from cancer and other causes after radiotherapy for ankylosing spondylitis. Br Med J 1965; 2: 1327-32. doi: 10.1136/bmj.2.5474.1327
78. Darby SC, Doll R, Gill SK, Smith PG. Long term mortality after a single treatment course with X-rays in patients treated for ankylosing spondylitis. Br J Cancer 1987; 55: 179-90. doi: 10.1038/bjc.1987.35
79. Carr ZA, Kleinerman RA, Stovall M, Weinstock RM, Griem ML, Land CE. Malignant neoplasms after radiation therapy for peptic ulcer. Radiat Res 2002; 157: 668-77. doi: 10.1667/0033-7587(2002)157 [0668:MNARTF]2.0.CO;2
80. Berrington de Gonzalez A, Curtis RE, Kry SF, Gilbert E, Lamart S, Berg CD, et al. Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries. Lancet Oncol 2011; 12: 353-60. doi: 10.1016/S1470-2045(11)70061-4
81. Berrington de Gonzalez A, Gilbert E, Curtis R, Inskip P, Kleinerman R, Morton L, et al. Second solid cancers after radiation therapy: a systematic review of the epidemio-logic studies of the radiation dose-response relationship. Int J Radiat Oncol Biol Phys 2013; 86: 224-33. doi: 10.1016/j. ijrobp.2012.09.001
82. Chaturvedi AK, Engels EA, Gilbert ES, Chen BE, Storm H, Lynch CF, et al. Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk. J Natl Cancer Inst 2007; 99: 1634-43. doi: 10.1093/ jnci/djm201
83. Meadows AT, Friedman DL, Neglia JP, Mertens AC, Donaldson SS, Stovall M, et al. Second neoplasms in survivors of childhood cancer: findings from the childhood cancer survivor study cohort. J Clin Oncol 2009; 27: 2356-62. doi: 10.1200/ JCO.2008.21.1920
84. Reulen RC, Frobisher C, Winter DL, Kelly J, Lancashire ER, Stiller CA, et al; British Childhood Cancer Survivor Study Steering Group. Long-term risks of subsequent primary neoplasms among survivors of childhood cancer. JAMA 2011; 305: 2311-19. doi: 10.1001/jama.2011.747
85. Wang JX, Zhang LA, Li BX, Zhao YC, Wang ZQ, Zhang JY, et al. Cancer incidence and risk estimation among medical X-ray workers in China, 1950-1995. Health Phys 2002; 82: 455-66. doi: 10.1097/00004032-200204000-00004
86. Shore RE, Albert RE, Reed M, Harley N, Pasternack BS. Skin cancer incidence among children irradiated for ringworm of the scalp. Radiat Res 1984; 100: 192-204. doi: 10.2307/3576533
87. Weiss HA, Darby SC, Doll R. Cancer mortality following X-ray treatment for ankylosing spondylitis. Int J Cancer 1994; 9: 327-38. doi: 10.1002/ijc.2910590307
88. Boice JD Jr, Day NE, Andersen A, Brinton LA, Brown R, Choi NW, et al. Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries. J Natl Cancer Inst 1985; 74: 955-75.
89. Pappo AS, Armstrong GT, Liu W, Srivastava DK, McDonald A, Leisenring WM, et al. Melanoma as a subsequent neoplasm in adult survivors of childhood cancer: a report from the childhood cancer survivor study. Pediatr Blood Cancer 2013; 60: 461-6. doi: 10.1002/pbc.24266
90. International Commission of Radiation Protection. The biological basis for dose limitation in the skin. A report of a Task Group of Committee 1 of the International Commission of Radiological Protection. Ann ICRP 1991; 22: 1-104.
91. Shore RE, Moseson M, Xue X, Tse Y, Harley N, Pasternack BS. Skin cancer after X-ray treatment for scalp ringworm. Radiat Res 2002; 157: 410-18. doi: 10.1667/0033-7587 (2002)157[0410:SCAXRT]2.0.CO;2
92. Trott KR, Kamprad F. Estimation of cancer risks from radiotherapy of benign diseases. Strahlenther Onkol 2006; 182: 431-36. doi: 10.1007/s00066-006-1542-8
93. Hassanpour SE, Kalantar-Hormozi A, Motamed S, Moosavizadeh SM, Shahver-diani R. Basal cell carcinoma of scalp in patients with history of childhood therapeutic radiation: a retrospective study and comparison to nonirradiated patients. Ann Plast Surg 2006; 57: 509-12. doi: 10.1097/01. sap.0000229002.09605.5d
94. Thompson DE, Mabuchi K, Ron E, Soda M, Tokunaga M, Ochikubo S, et al. Cancer incidence in atomic bomb survivors. Part II: Solid tumours, 1958-1987. Radiat Res 1994; 137(Suppl. 2): S17-67.
95. Sadamori N, Shibata S, Mine M, Miyazaki H, Miyake H, Kurihara M, et al. Incidence of intracranial meningiomas in Nagasaki atomic-bomb survivors. Int J Cancer 1996; 67: 318-22. doi: 10.1002/(SICI)1097-0215 (19960729)67:3,318::AID-IJC2.3.0.CO; 2-U
96. Bowers DC, Nathan PC, Constine L, Woodman C, Bhatia S, Keller K, et al. Subsequent neoplasms of the CNS among survivors of childhood cancer: a systematic review. Lancet Oncol 2013; 14: e321-8. doi: 10.1016/S1470-2045(13) 70107-4
97. Niranjan A, Kondziolka D, Lunsford LD. Neoplastic transformation after radiosur-gery or radiotherapy: risk and realities. Otolaryngol Clin North Am 2009; 42: 717-29. doi: 10.1016/j.otc.2009.04.005
98. Yanamadala V, Williamson RW, Fusco DJ, Eschbacher J, Weisskopf P, Porter RW. Malignant transformation of a vestibular schwannoma after gamma knife radiosur-gery. World Neurosurg 2013; 79: 593.e1-8. doi: 10.1016/j.wneu.2012.03.016
99. Kubo O, Chernov M, Izawa M, Hayashi M, Muragaki Y, Maruyama T, et al. Malignant progression of benign brain tumors after gamma knife radiosurgery: is it really caused by irradiation? Minim Invasive Neurosurg 2005; 48: 334-9. doi: 10.1055/s-2005-915632
100. Ainsbury EA, Bouffler SD, Dörr W, Graw J, Muirhead CR, Edwards AA, et al. Radiation cataractogenesis: a review of recent studies. Radiat Res 2009; 172: 1-9. doi: 10.1667/ RR1688.1
101. Neriishi K, Nakashima E, Akahoshi M, Hida A, Grant EJ, Masunari N, et al. Radiation dose and cataract surgery incidence in atomic bomb survivors, 1986-2005. Radiology 2012; 265: 167-74. doi: 10.1148/radiol.12111947
102. Authors on behalf of ICRP, Stewart FA, Akleyev AV, Hauer-Jensen M, Hendry JH, Kleiman NJ, Macvittie TJ, et al. ICRP publication 118: ICRP statement on tissue reactions and early and late effects of radiation in normal tissues and organs-threshold doses for tissue reactions in a radiation protection context. Ann ICRP 2012; 41: 1-322. doi: 10.1016/j.icrp.2012.02.001
103. Inskip PD, Kleinerman RA, Stovall M, Cookfair DL, Hadjimichael O, Moloney WC, et al. Leukaemia, lymphoma, and multiple myeloma after pelvic radiotherapy for benign disease. Radiat Res 1993; 135: 108-24. doi: 10.2307/3578404
104. Little MP, Weiss HA, Boice JD Jr, Darby SC, Day NE, Muirhead CR. Risks of leukemia in Japanese atomic bomb survivors, in women treated for cervical cancer, and in patients treated for ankylosing spondylitis. Radiat Res 1999; 152: 280-92. doi: 10.2307/3580328
105. Preston DL, Shimizu Y, Pierce DA, Suyama A, Mabuchi K. Studies on mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997. Radiat Res 2003; 160: 381-407. doi: 10.1667/RR3049
106. Draper GJ, Sanders BM, Kingston JE. Second primary neoplasms in patients with retinoblastoma. Br J Cancer 1986; 53: 661-71. doi: 10.1038/bjc.1986.110
107. Burnet NG, Nasr P, Yip G, Scaife JE, House T, Thomas SJ, et al. Prophylactic radiotherapy against heterotopic ossification following internal fixation of acetabular fractures: a comparative estimate of risk. Br J Radiol 2014; 87: 20140398. doi: 10.1259/ bjr.20140398
108. Eidemüller M, Holmberg E, Jacob P, Lundell M, Karlsson P. Breast cancer risk after radiation treatment at infancy: potential consequences of radiation-induced genomic instability. Radiat Prot Dosimetry 2011; 143: 375-9. doi: 10.1093/rpd/ncq473
109. Guibout C, Adjadj E, Rubino C, Shamsaldin A, Grimaud E, Hawkins M, et al. Malignant breast tumors after radiotherapy for a first cancer during childhood. J Clin Oncol 2005; 23: 197-204. doi: 10.1200/JCO.2005.06.225
110. Hodgson DC, Koh ES, Tran TH, Heydarian M, Tsang R, Pintilie M, et al. Individualized estimates of second cancer risks after contemporary radiation therapy for Hodg-kin lymphoma. Cancer 2007; 110: 2576-86. doi: 10.1002/cncr.23081
111. Furukawa K, Preston DL, Lönn S, Funamoto S, Yonehara S, Matsuo T. Radiation and smoking effects on lung cancer incidence among atomic bomb survivors. Radiat Res 2010; 174: 72-82. doi: 10.1667/RR2083.1